Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Godavari Drugs Ltd. Share Price
Day's Range
Day's Range
Low
₹
High
₹
Price Summary
| Previous Close | ₹125.20 |
|---|---|
| Day's Range | ₹120.30 - ₹131.00 |
| Open | ₹124.00 |
| 52 Week Range | ₹69.70 - ₹132.96 |
| Volume | 23,971 |
| Market Cap | ₹0.00 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 30.01 |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 0.00 |
| Price/Earning (TTM) | 33.83 |
| TTM EPS (₹) | 3.65 |
| P/E Ratio | 15.04 |
| Book Value(₹) | 2.56 |
| PAT Margin (%) | 3.86 |
| Face Value (₹) | 10.00 |
| ROCE(%) | 10.13 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 295.52 | 1567.12 |
| Expenses | N/A | N/A |
| PBT | 9.22 | 69.22 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 7.67 | 55.49 |
About Godavari Drugs Ltd.
| Founded | 1987 |
|---|---|
| Managing Director | Mukund Kakani |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,33,847.75 | 1,824.10 | 1,548.00 - 1,548.00 |
| Divi's Laboratories Ltd. | 1,72,696.60 | 6,618.20 | 5,636.50 - 5,636.50 |
| Torrent Pharmaceuticals Ltd. | 1,41,859.41 | 4,252.05 | 3,101.60 - 3,101.60 |
| Dr. Reddy's Laboratories Ltd. | 1,10,420.94 | 1,287.95 | 1,129.40 - 1,129.40 |
| Apollo Hospitals Enterprise Ltd. | 1,09,839.98 | 7,727.50 | 6,677.50 - 6,677.50 |
| Cipla Ltd. | 1,05,811.45 | 1,334.85 | 1,165.70 - 1,165.70 |
| Lupin Ltd. | 1,05,320.35 | 2,350.00 | 1,836.80 - 1,836.80 |
| Max Healthcare Institute Ltd. | 96,662.57 | 1,011.45 | 903.00 - 903.00 |
| Mankind Pharma Ltd. | 92,743.95 | 2,266.80 | 1,909.70 - 1,909.70 |
| Zydus Lifesciences Ltd. | 89,720.85 | 901.65 | 835.50 - 835.50 |
No Records Found
Latest News
Godavari Drugs informs about certificate
Godavari Drugs has informed that it enclosed certificate issued by CIL Securities, Registrar and Share transfer Agent dated 07th April, 2026 confirming the compliance of regulation 74 (5) of SEBI (Depository and Participants) Regulations, 2018 for the quarter ended March 31, 2026.
The above information is a part of company’s filings submitted to BSE.
Godavari Drugs informs about trading window closure
Godavari Drugs informs about disclosures
Godavari Drugs informs about press release
Albert David informs about board meeting
In terms of Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Albert David has informed that a meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, the May 12, 2026, to: 1. Consider, approve and take on record the Audited Financial Results of the Company for the Fourth Quarter and Financial Year ended on March 31, 2026. 2. Consider recommendation of Final Dividend, if any, for the Financial Year ended on March 31, 2026. The trading window for dealing in equity shares of the Company is already closed from April 1, 2026, and shall open 48 hours post declaration of the above results. The above notice is also being made available on the website of the Company at www.albertdavidindia.com.
The above information is a part of company’s filings submitted to BSE.
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Godavari Drugs Ltd. is ₹125.20 as of 2026-05-04.
The market capitalisation of Godavari Drugs Ltd. is ₹124.89 as of 2026-04-30.
The 1-year return of Godavari Drugs Ltd. is 36.19% as of 2025-05-02.
The P/E ratio of Godavari Drugs Ltd. is 15.04 as of 2026-05-04.
The 52-week high and low of Godavari Drugs Ltd. are ₹132.96 and ₹69.70, respectively, as of 2026-05-04.
Disclaimer
This content is for educational purpose only and the same should not be construed as investment advice. Bajaj Finserv Direct Limited shall not be liable or responsible for any investment decision that you may take based on this content.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
